Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

CDKN1B inhibits UCHL1. 1 / 1

| 1

➶

reach

"Results of multiple Western blot analysis showed that pro apoptotic factors, Fas, Fas-L, Trail, DR4, DR5, Bax, cytochrome C, active caspase-3 and phospho-p53 levels were remarkably higher (XREF_FIG), anti-apoptotic factors, phospho-Mdm-2, Bcl-2 and Bcl-xL levels were significantly lower (XREF_FIG), cyclin dependent kinase inhibitor p21 level was elevated, while p27 level was reduced (XREF_FIG) in UCH-L1 transfectants than in MCF7 cells and their empty loading control transfectants."

18949367

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...